Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP217245.RAhWiaEDH-StDyk6_jt5GNi_yptuGr2cXMW51TdaFf_dg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP217245.RAhWiaEDH-StDyk6_jt5GNi_yptuGr2cXMW51TdaFf_dg130_assertion type Assertion NP217245.RAhWiaEDH-StDyk6_jt5GNi_yptuGr2cXMW51TdaFf_dg130_head.
- NP217245.RAhWiaEDH-StDyk6_jt5GNi_yptuGr2cXMW51TdaFf_dg130_assertion description "[In light of the beneficial effects in EAE in vivo and the in vitro immunosuppressive and pro-apoptotic capacities in cultured human mononuclear immune effector cells, these data may support a potential role of treosulfan, an agent with high immunosuppressive capacity and low toxicity, in the treatment of MS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217245.RAhWiaEDH-StDyk6_jt5GNi_yptuGr2cXMW51TdaFf_dg130_provenance.
- NP217245.RAhWiaEDH-StDyk6_jt5GNi_yptuGr2cXMW51TdaFf_dg130_assertion evidence source_evidence_literature NP217245.RAhWiaEDH-StDyk6_jt5GNi_yptuGr2cXMW51TdaFf_dg130_provenance.
- NP217245.RAhWiaEDH-StDyk6_jt5GNi_yptuGr2cXMW51TdaFf_dg130_assertion SIO_000772 14597095 NP217245.RAhWiaEDH-StDyk6_jt5GNi_yptuGr2cXMW51TdaFf_dg130_provenance.
- NP217245.RAhWiaEDH-StDyk6_jt5GNi_yptuGr2cXMW51TdaFf_dg130_assertion wasDerivedFrom befree-20140225 NP217245.RAhWiaEDH-StDyk6_jt5GNi_yptuGr2cXMW51TdaFf_dg130_provenance.
- NP217245.RAhWiaEDH-StDyk6_jt5GNi_yptuGr2cXMW51TdaFf_dg130_assertion wasGeneratedBy ECO_0000203 NP217245.RAhWiaEDH-StDyk6_jt5GNi_yptuGr2cXMW51TdaFf_dg130_provenance.